GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » THC Therapeutics Inc (OTCPK:THCT) » Definitions » Sale Of Investment

THCT (THC Therapeutics) Sale Of Investment : $0.00 Mil (TTM As of Apr. 2024)


View and export this data going back to 2007. Start your Free Trial

What is THC Therapeutics Sale Of Investment?

THC Therapeutics's sale of investment for the three months ended in Apr. 2024 was $0.00 Mil. It means THC Therapeutics gained $0.00 Mil from selling investments. THC Therapeutics's sale of investment for the trailing twelve months (TTM) ended in Apr. 2024 was $0.00 Mil.

Compared with last quarter ($0.00 Mil in Jan. 2024 ), THC Therapeutics gained the same money from selling investments in Apr. 2024 ($0.00 Mil).


THC Therapeutics Sale Of Investment Historical Data

The historical data trend for THC Therapeutics's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

THC Therapeutics Sale Of Investment Chart

THC Therapeutics Annual Data
Trend Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23
Sale Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

THC Therapeutics Quarterly Data
Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
Sale Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

THC Therapeutics Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Apr. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


THC Therapeutics Sale Of Investment Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.


THC Therapeutics Business Description

Traded in Other Exchanges
N/A
Address
11700 W Charleston Boulevard, No. 73, Las Vegas, NV, USA, 89135
Website
THC Therapeutics Inc is a United States-based company. It is focused on developing a sanitizing herb dryer, the dHydronator, which has been specifically designed for the drying and sanitizing i.e., reducing the bacterial count of freshly harvested cannabis, and other herbs, flowers, and tea leaves. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis.
Executives
Hiro Tanaka director, officer: Vice President 3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Smith Adrian J R director, officer: Chair of the Board 119 SPRINGLINE DRIVE, VERO BEACH FL 32963
Jamie Mann director, 10 percent owner, officer: CEO, CFO 3RD FLOOR, 207 REGENT STREET, LONDON X0 W1B 3HH
Eden Ho director, officer: CEO 701 XUANG MI HU ROAD, XI YUAN, FUTIAN, SHENZHEN F4 XXXXXX